Organic anion-transporting polypeptides contribute to the hepatic uptake of berberine

References

• Borrelli F, Izzo AA. (2009). Herb--drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations. AAPS J 11:710–27
   PubMed Web of Science ®Google Scholar
• Chen CM, Chang HC. (1995). Determination of berberine in plasma, urine and bile by high-performance liquid chromatography. J Chromatogr B 665:117–23
   PubMed Web of Science ®Google Scholar
• Chen W, Miao YQ, Fan DJ, et al. (2011). Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. AAPS PharmSciTech 12:705–11
   PubMed Web of Science ®Google Scholar
• Derosa G, Maffioli P. (2014). Alkaloids in the nature: pharmacological applications in clinical practice of berberine and mate tea. Curr Top Med Chem 14:200–6
   PubMed Web of Science ®Google Scholar
• Glaeser H, Bujok K, Schmidt I, et al. (2014). Organic anion transporting polypeptides and organic cation transporter 1 contribute to the cellular uptake of the flavonoid quercetin. Naunyn Schmiedebergs Arch Pharmacol 387:883–91
   PubMed Web of Science ®Google Scholar
• Godugu C, Patel AR, Doddapaneni R, et al. (2014). Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid. PLoS One 9:e89919
   PubMed Web of Science ®Google Scholar
• Guo C, He L, Yao D, et al. (2014). Alpha-naphthylisothiocyanate modulates hepatobiliary transporters in sandwich-cultured rat hepatocytes. Toxicol Lett 224:93–100
   PubMed Web of Science ®Google Scholar
• Heidarian E, Rafieian-Kopaei M, Khoshdel A, Bakhshesh M. (2014). Metabolic effects of berberine on liver phosphatidate phosphohydrolase in rats fed on high lipogenic diet: an additional mechanism for the hypolipidemic effects of berberine. Asian Pac J Trop Biomed 4:S429–35
   PubMedGoogle Scholar
• Ismair MG, Stanca C, Ha HR, et al. (2003). Interactions of glycyrrhizin with organic anion transporting polypeptides of rat and human liver. Hepatol Res 26:343–7
   PubMed Web of Science ®Google Scholar
• Kindla J, Fromm MF, Konig J. (2009). In vitro evidence for the role of OATP and OCT uptake transporters in drug--drug interactions. Expert Opin Drug Metab Toxicol 5:489–500
   PubMed Web of Science ®Google Scholar
• Kwon M, Choi YA, Choi MK, Song IS. (2015). Organic cation transporter-mediated drug--drug interaction potential between berberine and metformin. Arch Pharm Res 38:849--56
   PubMed Web of Science ®Google Scholar
• Lau YY, Okochi H, Huang Y, Benet LZ. (2006). Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems. J Pharm Exp Ther 316:762–71
   PubMed Web of Science ®Google Scholar
• Lee SY, Jang H, Lee JY, et al. (2014). Inhibitory effects of Hwang-Ryun-Hae-Dok-Tang on cytochrome P450 in human liver microsomes. Xenobiotica 45:131–8
   PubMed Web of Science ®Google Scholar
• Liu LZ, Cheung SC, Lan LL, et al. (2010a). Berberine modulates insulin signaling transduction in insulin-resistant cells. Mol Cell Endocrinol 317:148–53
   PubMed Web of Science ®Google Scholar
• Liu Y, Hao H, Xie H, et al. (2009). Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of berberine in rats. J Pharm Sci 98:4391–401
   PubMed Web of Science ®Google Scholar
• Liu YT, Hao HP, Xie HG, et al. (2010b). Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metab Dispos 38:1779–84
   PubMed Web of Science ®Google Scholar
• Martin PD, Warwick MJ, Dane AL, et al. (2003). Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers. Clin Ther 25:2553–63
   PubMed Web of Science ®Google Scholar
• Meng Q, Liu Q, Wang C, et al. (2010). Molecular mechanisms of biliary excretion of cefditoren and the effects of cefditoren on the expression levels of hepatic transporters. Drug Metab Pharmacokinet 25:320–7
   PubMed Web of Science ®Google Scholar
• Nies AT, Herrmann E, Brom M, Keppler D. (2008). Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1). Aunyn Schmiedebergs Arch Pharmacol 376:449–61
   PubMed Web of Science ®Google Scholar
• Pan GY, Wang GJ, Liu XD, et al. (2002). The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol 91:193–7
   PubMedGoogle Scholar
• Roth M, Obaidat A, Hagenbuch B. (2012). OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol 165:1260–87
   PubMed Web of Science ®Google Scholar
• Ruschitzka F, Meier PJ, Turina M, et al. (2000). Acute heart transplant rejection due to Saint John's wort. Lancet 355:548–9
   PubMed Web of Science ®Google Scholar
• Sheng J, Tian X, Xu G, et al. (2015). The hepatobiliary disposition of timosaponin b2 is highly dependent on influx/efflux transporters but not metabolism. Drug Metab Dispos 43:63–72
   PubMed Web of Science ®Google Scholar
• Shitara Y, Sugiyama D, Kusuhara H, et al. (2002). Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)- and Oatp2 (Slc21a5)-mediated transport. Pharm Res 19:147–53
   PubMed Web of Science ®Google Scholar
• Shitara Y, Sugiyama Y. (2006). Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug--drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacol Ther 112:71–105
   PubMed Web of Science ®Google Scholar
• Tan KW, Li Y, Paxton JW, et al. (2013). Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2). Food Chem 138:2267–74
   PubMed Web of Science ®Google Scholar
• Tan S, Yu W, Lin Z, et al. (2015). Berberine ameliorates intestinal mucosal barrier damage induced by peritoneal air exposure. Biol Pharm Bull 38:122–6
   PubMed Web of Science ®Google Scholar
• Wu ZT, Qi XM, Sheng JJ, et al. (2014). Timosaponin A3 induces hepatotoxicity in rats through inducing oxidative stress and down-regulating bile acid transporters. Acta Pharmacol Sin 35:1188–98
   PubMed Web of Science ®Google Scholar
• Yoshida K, Maeda K, Sugiyama Y. (2013). Hepatic and intestinal drug transporters: prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphisms. Annu Rev Pharmacol Toxicol 53:581–612
   PubMed Web of Science ®Google Scholar
• Zhang A, Wang C, Liu Q, et al. (2013). Involvement of organic anion-transporting polypeptides in the hepatic uptake of dioscin in rats and humans. Drug Metab Dispos 41:994–1003
   PubMed Web of Science ®Google Scholar
• Zhang H, Wei J, Xue R, et al. (2010). Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism 59:285–92
   PubMed Web of Science ®Google Scholar
• Zuo F, Nakamura N, Akao T, Hattori M. (2006). Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry. Drug Metab Dispos 34:2064–72
   PubMed Web of Science ®Google Scholar